Charles A. Reinhart
Director of Finance/CFO presso PACIRA BIOSCIENCES, INC.
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Charles A.
Reinhart is currently the Director at Vectorlogics, Inc. and the Chief Financial Officer at Pacira Biosciences, Inc. He was previously the Independent Director at Osiris Therapeutics, Inc., Vice President-Finance at Cephalon, Inc., Senior Vice President-Finance & Strategy at Millennium Pharmaceuticals, Inc., Principal at GenVec, Inc. and Delsys Pharmaceutical Corp., Chief Financial Officer & Executive Vice President at Archimedes Pharma Ltd., Chief Financial Officer & Senior Vice President at PharmAthene, Inc., and Chief Financial Officer at Covis Pharmaceuticals, Inc. Reinhart received his undergraduate degree from Lehigh University in 1982 and his MBA from The Wharton School of the University of Pennsylvania in 1990.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
PACIRA BIOSCIENCES, INC.
0.09% | 14/06/2023 | 42 626 ( 0.09% ) | 1 M $ | 31/03/2024 |
Posizioni attive di Charles A. Reinhart
| Società | Posizione | Inizio |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Director of Finance/CFO | 01/05/2016 |
Vectorlogics, Inc.
 Vectorlogics, Inc. BiotechnologyHealth Technology Vectorlogics, Inc. develops and commercialized vaccines for virus based cancer therapies and viral liver diseases. The company was founded by David T. Curiel in 1998 and is headquartered in Birmingham, AL. | Director/Board Member | 09/10/2009 |
Precedenti posizioni note di Charles A. Reinhart
| Società | Posizione | Fine |
|---|---|---|
| OSIRIS THERAPEUTICS, INC. | Director/Board Member | 17/04/2019 |
Covis Pharmaceuticals, Inc.
 Covis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Covis Pharmaceuticals, Inc. specializes and distributes pharmaceutical products. It is a specialty pharmaceutical distributor dedicated to improving the lives of people with life-threatening conditions and chronic illnesses. The company was founded on November 2, 2011 and is headquartered in Chesterbrook, PA. | Director of Finance/CFO | 01/10/2015 |
Archimedes Pharma Ltd.
 Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom. | Director of Finance/CFO | 01/08/2014 |
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Director of Finance/CFO | 07/09/2011 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/06/2008 |
Formazione di Charles A. Reinhart
| Lehigh University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PACIRA BIOSCIENCES, INC. | Health Technology |
| Aziende private | 9 |
|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
Delsys Pharmaceutical Corp.
 Delsys Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Delsys Pharmaceutical Corp. is a pharmaceutical manufacturing company. The private company is based in Princeton, NJ. | Health Technology |
Archimedes Pharma Ltd.
Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |
Vectorlogics, Inc.
Vectorlogics, Inc. BiotechnologyHealth Technology Vectorlogics, Inc. develops and commercialized vaccines for virus based cancer therapies and viral liver diseases. The company was founded by David T. Curiel in 1998 and is headquartered in Birmingham, AL. | Health Technology |
Covis Pharmaceuticals, Inc.
Covis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Covis Pharmaceuticals, Inc. specializes and distributes pharmaceutical products. It is a specialty pharmaceutical distributor dedicated to improving the lives of people with life-threatening conditions and chronic illnesses. The company was founded on November 2, 2011 and is headquartered in Chesterbrook, PA. | Health Technology |
- Borsa valori
- Insiders
- Charles A. Reinhart
